<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Amelia Lorensia</style></author><author><style face="normal" font="default" size="100%">Rivan Virlando Suryadinata</style></author><author><style face="normal" font="default" size="100%">Dita Sukmaya Prawitasari</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Knowledge and Perception of the Risk of Respiration Disorders in COVID-19 Pandemic in COPD Patient: A Mixed-Method Study</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">COPD</style></keyword><keyword><style  face="normal" font="default" size="100%">COVID-19</style></keyword><keyword><style  face="normal" font="default" size="100%">knowledge</style></keyword><keyword><style  face="normal" font="default" size="100%">Perception.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">October 2023</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">15</style></volume><pages><style face="normal" font="default" size="100%">801-810</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; Chronic obstructive pulmonary disease (COPD) have a higher risk for COVID-19-related complications. Knowledge and perception will greatly influence the behavior of a COPD patient in dealing with a problem, such as the risk of COVID-19 infection. The purpose of the study was to determine knowledge and perceptions about the risk of respiration disorders during the COVID-19 pandemic in COPD patients. This research was a mixed methods research with an explanatory sequential research design. The location was conducted in Rungkut District in Surabaya City, East Java, from May-October 2022. Sampling by purposive sampling method, and analyzed descriptively. The research sample was 116 people. On the knowledge, the most correct answers were the COVID-19 virus was contagious (112 of 116). On the perception, the answer with the most positive level is a question regarding the use of masks. Some respondents had a low knowledge category (54 of 116), and the most positive perception category (57 of 116). The respondents' knowledge of the COVID-19 virus showed COVID-19 virus was a contagious disease and was transmitted through air. But many respondents didn’t know about the type of COVID-19 virus. Therefore, it was necessary to develop a strategy to increase knowledge about COVID-19 and related COPD treatment.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><section><style face="normal" font="default" size="100%">801</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Amelia Lorensia&lt;sup&gt;1,*&lt;/sup&gt;, Rivan Virlando Suryadinata&lt;sup&gt;2&lt;/sup&gt;, Dita Sukmaya Prawitasari&lt;sup&gt;3&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Faculty of Pharmacy, University of Surabaya, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Faculty of Medicine, University of Surabaya, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Faculty of Medicine, University of Surabaya, Indonesia.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Fajar Herbowo Niantiarno</style></author><author><style face="normal" font="default" size="100%">Agus Turchan</style></author><author><style face="normal" font="default" size="100%">Myrna Adianti</style></author><author><style face="normal" font="default" size="100%">Budi Utomo</style></author><author><style face="normal" font="default" size="100%">Muhammad Arifin Parenrengi</style></author><author><style face="normal" font="default" size="100%">Abdul Hafid Bajamal</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Kaempferia galanga L. Extract Administration Attenuate Aquaporin-4 Expression in Traumatic Brain Injury: An Experimental Study in Rats</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Ayuverdic medicine</style></keyword><keyword><style  face="normal" font="default" size="100%">Neuroinflammation</style></keyword><keyword><style  face="normal" font="default" size="100%">Neurotrauma</style></keyword><keyword><style  face="normal" font="default" size="100%">Post-traumatic cerebral edema</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">January 2023</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">893-897</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Traumatic brain injury (TBI) is still a major health problem in the world. It might cause long-term disability that affect socio-economic life and become nation health burden. Post-traumatic cerebral edema might develop and commit to an unfavorable prognosis. Aquaporin 4 (AQP4) is water channel protein and a key regulator of water metabolism in the brain. Although the mechanism of AQP4 in the regulation of post-traumatic brain edema remains controversial, AQP4-lacking mice show better survival and decreased brain edema. Thus, novel strategies that suppress AQP4 become a potential field. We hypothesized that &lt;em&gt;Kaempferia galanga&lt;/em&gt; L. may suppress brain expression of AQP4 following TBI and possibly limit the development of cerebral edema due to its neuroinflammation properties. &lt;strong&gt;Method:&lt;/strong&gt; We conducted TBI to experimental rats, then given &lt;em&gt;Kaempferia galanga &lt;/em&gt;L. extract at a dose of 600 mg/kg BW and 1200 mg/kg BW. Evaluation intensity of AQP4 expression by immunohistochemistry was performed 24 and 48 hours later to see its therapeutic effect. &lt;strong&gt;Results:&lt;/strong&gt; Administration of &lt;em&gt;Kaempferia galanga &lt;/em&gt;L. extract at a dose of 1200 mg/kg BW showed weak expression of AQP4 in all samples, both 24 and 48 hours following traumatic brain injury treatment. &lt;strong&gt;Conclusions&lt;/strong&gt;: Intensity of AQP4 expression in rats’ brain was lower at 24 and 48 hours after TBI in rats receiving &lt;em&gt;Kaempferia galanga&lt;/em&gt; L. extract with dose 1200 mg/ kg BW compared to the other groups. Our result indicates that &lt;em&gt;Kaempferia galanga &lt;/em&gt;L. might affect the expression of brain AQP4 in a dose-dependent manner.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6s</style></issue><work-type><style face="normal" font="default" size="100%">Original Article </style></work-type><section><style face="normal" font="default" size="100%">893</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Fajar Herbowo Niantiarno&lt;sup&gt;1&lt;/sup&gt;, Agus Turchan&lt;sup&gt;1,*&lt;/sup&gt;, Myrna Adianti&lt;sup&gt;2&lt;/sup&gt;, Budi Utomo&lt;sup&gt;3&lt;/sup&gt;, Muhammad Arifin Parenrengi&lt;sup&gt;1&lt;/sup&gt;, Abdul Hafid Bajamal&lt;sup&gt;1&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Neurosurgery, Faculty of Medicine Universitas Airlangga – Dr. Soetomo Academic General Hospital, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Traditional Medicine Study Program, Department of Health, Faculty of Vocational Studies, Universitas Airlangga, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Public Health Science and Preventive Medicine, Faculty of Medicine Universitas Airlangga, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Inbaraj Susai Domnic</style></author><author><style face="normal" font="default" size="100%">Faisal Fahad Al Otaibi</style></author><author><style face="normal" font="default" size="100%">Noureldaim Elnoman Elbadawi</style></author><author><style face="normal" font="default" size="100%">Prasanna Mohana Bhaskaran</style></author><author><style face="normal" font="default" size="100%">Mohammad Azhar Rashikh</style></author><author><style face="normal" font="default" size="100%">Dinesh Dimri</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Knowledge and Awareness about Pharmacogenomics and Personalized Medicine Among the Students of College of Medicine, Shaqra university in Dawadmi, Kingdom of Saudi Arabia</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Personalized medicine</style></keyword><keyword><style  face="normal" font="default" size="100%">Pharmacogenetic testing</style></keyword><keyword><style  face="normal" font="default" size="100%">Pharmacogenomics</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">August 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">367-372</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Pharmacogenomics and personalized medicine are the two rapidly emerging areas in medical field which will determine the drug therapy of the future. It is very important for current medical students to be aware of these medical fields and apply these principles in their medical practice. There is huge scope for research in this area, hence an awareness study was conducted among medical students of college of medicine, Shaqra university, Dawadmi.&lt;strong&gt; Methods: &lt;/strong&gt;A cross sectional questionnaire-based study was conducted among the medical students of Shaqra university, Dawadmi by self-administered questionnaire. 150 students participated in the study. &lt;strong&gt;Results: &lt;/strong&gt;Out of the 150 students participated in the study Pharmacogenomics is relevant to my education 25% strongly agree. 45% agreed to recommend pharmacogenomic testing. Familiarity with genetics is only 16% and only 14% are familiar with interpreting results of pharmacogenomic tests. Knowledge testing showed overall less percentage. Only 16% can identify drugs that require pharmacogenomic testing. But 36% are confident to use the results of pharmacogenomics tests to make an appropriate adjustment to a patient’s drug therapy. Knowledge about personalized medicine is 31% with scale of 3 out of 7.40% of students agreed to undergo genetic testing. 52% of the participants agreed to know about their risk for developing genetic based chronic diseases. &lt;strong&gt;Conclusion&lt;/strong&gt;: There is genuine interest and awareness about Pharmacogenomics and Personalized medicine among the medical students but the knowledge is lacking. Hence including these areas in the undergraduate medical curriculum will impart valuable knowledge to the future medical students.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Research Article </style></work-type><accession-num><style face="normal" font="default" size="100%">17</style></accession-num><section><style face="normal" font="default" size="100%">367</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Inbaraj Susai Domnic&lt;sup&gt;1,*&lt;/sup&gt;, Faisal Fahad Al Otaibi&lt;sup&gt;2&lt;/sup&gt;, Noureldaim Elnoman Elbadawi&lt;sup&gt;1&lt;/sup&gt;, Prasanna Mohana Bhaskaran&lt;sup&gt;1&lt;/sup&gt;, Mohammad Azhar Rashikh&lt;sup&gt;1&lt;/sup&gt;, Dinesh Dimri&lt;sup&gt;1&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Faculty, College of Medicine, Shaqra University, Dawadmi, Kingdom of Saudi Arabia, SAUDI ARABIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Medical student, College of Medicine, Shaqra University, Dawadmi, Kingdom of Saudi Arabia, SAUDI ARABIA.&lt;/p&gt;
</style></auth-address></record></records></xml>